...
首页> 外文期刊>Arquivos de Neuro-Psiquiatria >A study on the action of two calcium channel blockers (verapamil and flunarizine) upon an experimental model of tardive dyskinesia in rats
【24h】

A study on the action of two calcium channel blockers (verapamil and flunarizine) upon an experimental model of tardive dyskinesia in rats

机译:两种钙通道阻滞剂(维拉帕米和氟尿利嗪)对大鼠迟发性运动障碍实验模型的作用研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Tardive dyskinesia (TD), a serious complications of neuroleptic chronic use, has no effective therapy yet. We performed an experiment to study the action on TD, of the calcium channel blockers (CCB) drugs, verapamil and flunarizine. We obtained the TD model in rats, administering haloperidol for a 21-day period. After this, the stereotyped movement induced by apomorphyne was rated. The CCB drugs were administered in acute (in the 28th. day) and chronic (for 8 days, after the 25th day) experiments. Acutely, verapamil increased the stereotyped behaviour, and promoted a reduction of it in the chronic experiment. The results suggest that CCB drugs should be tested in clinical trials of TD.
机译:迟发性运动障碍(TD)是精神安定剂长期使用的严重并发症,目前尚无有效的治疗方法。我们进行了一项实验,研究钙通道阻滞剂(CCB),维拉帕米和氟硝利嗪对TD的作用。我们在大鼠中施用氟哌啶醇21天,获得了TD模型。此后,对由阿朴吗啡引起的定型运动进行了评估。 CCB药物在急性(第28天)和慢性(第25天后的8天)实验中给药。急性地,维拉帕米可增加定型行为,并在慢性实验中促进其减少。结果表明CCB药物应在TD的临床试验中进行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号